REZLIDHIA Net Product Sales for Q4 2024: $7.4 million, a 92% increase year over year ... Expected Net Product Sales for 2025: ...
Before you invest in Rigel Pharmaceuticals, Inc. (RIGL), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.
Analysts at HC Wainwright issued their Q3 2025 EPS estimates for Rigel Pharmaceuticals in a research report issued to clients ...
Equities research analysts at B. Riley issued their Q1 2025 EPS estimates for shares of Rigel Pharmaceuticals in a research note issued on Tuesday, March 4th. B. Riley analyst K. Patel expects that ...
B. Riley raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $24 from $20 and keeps a Neutral rating on the shares following the Q4 report. The upside was driven primarily by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results